AS
CSTL icon

Altshuler Shaham’s Castle Biosciences CSTL Stock Holding History

Altshuler Shaham’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-558
Closed -$38K – 635
2021
Q1 		$38K Sell
558
-113
-17% -$8.49K ﹤0.01% 331
2020
Q4 		$45K Buy
671
+137
+26% +$7.43K ﹤0.01% 276
2020
Q3 		$27K Buy
+534
New +$23.8K ﹤0.01% 293
2020
Q1 		– Sell
-481
Closed -$17K – 484
2019
Q4 		$17K Buy
+481
New +$11.8K ﹤0.01% 273

Other funds holding CSTL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $691M AUM 27.96% 1-Year Est. Return

Altshuler Shaham's CSTL Position: Q2 2021 in Review

Altshuler Shaham sold out of Castle Biosciences (CSTL) in Q2 2021, closing a stake of 558 shares — an estimated $38K sold.

Altshuler Shaham first reported a position in CSTL in Q4 2019 and held it in 4 quarters. The position peaked at $45K in Q4 2020. 181 funds tracked by Wall St. Rank hold CSTL as of Q2 2021.

  • Altshuler Shaham reported no remaining Castle Biosciences position as of Q2 2021 after selling out during the quarter.
  • Altshuler Shaham sold 558 Castle Biosciences shares in Q2 2021, an estimated $38K.
  • Altshuler Shaham first reported a position in Castle Biosciences in Q4 2019 and held it in 4 quarters.
  • Altshuler Shaham's Castle Biosciences position peaked at $45K in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2021.

Based on Altshuler Shaham's 13F filing for Q2 2021, filed 16 Aug 2021.